Home
Reels
Groups
Pages
See More
Groups Pages Blogs
Log In Register
Light Theme
Febrile Neutropenia Market Drivers, Challenges, and Forecast 2032
The Febrile Neutropenia Market is gaining strategic importance within the global oncology and infectious disease treatment landscape. Febrile neutropenia (FN) is a serious complication commonly associated with chemotherapy, characterized by fever and a significant reduction in neutrophil count, leaving patients highly vulnerable to infections. In 2024, the market was valued at US$ 10,789.45...
0 Comments ·0 Shares ·29 Views ·0 Reviews
Please log in to like, share and comment!